Results 151 to 160 of about 5,434 (205)

Case Report: Agranulocytosis in a Child Following Metamizole Use - A Diagnostic Challenge. [PDF]

Acta Med Acad
Pirnat A, Prelog T, Jazbec J, Trampuš Bakija A.   +3 more
europepmc   +1 more source

Kounis Syndrome: An Entity One Should Not Forget. [PDF]

Cureus
Paulo J, Marto D, Figueiredo F, Oliveira J, Costa M.   +4 more
europepmc   +1 more source

Advise against metamizole.

Deutsches Arzteblatt international, 2009
openaire   +1 more source

Drug Excipients. Necessary but Not Harmless.

Farm Comunitarios
Baixauli-Fernández VJ.
europepmc   +1 more source

Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients

European Journal of Internal Medicine, 2019
Reports of metamizole-induced neutropenia have increased in Switzerland and Germany over the last decades, most likely reflecting increased use of metamizole. To date, there are no effective strategies to identify patients at increased risk of metamizole-induced neutropenia.
Deborah Rüdin, Julia Spoendlin, Evangelia Liakoni   +2 more
exaly   +6 more sources

Safety of metamizole: a systematic review of the literature

Journal of Clinical Pharmacy and Therapeutics, 2016
Metamizole was withdrawn from the market in the United States and several European countries following reports of fatal agranulocytosis among users, but is still available in many countries in Europe, South America and Asia. Over the past several decades, a number of epidemiologic studies have been conducted to quantify the risk of agranulocytosis and ...
R Lange, J Gurwitz
exaly   +5 more sources

Regional Differences in Prescribing Patterns of Metamizole in Germany Based on Data from 70 Million Persons

International Journal of Environmental Research and Public Health, 2020
The non-opioid analgesic metamizole (dipyrone) is commonly used in Germany despite its narrow indications and market withdrawal from several countries. In this study we analyzed prescribing patterns of metamizole focusing on regional differences.
Falk Hoffmann, Carsten Bantel, Frederik Tilmann Von Rosen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A metamizol

Lege Artis Medicinae, 2020
A közel 100 éve alkalmazott metamizol napjainkban reneszánszát éli, az évek során bizonyította hatékonyságát és kivívta népszerűségét. Különleges hármas (fájdalomcsillapító, lázcsillapító és görcsoldó) hatása révén széles az indikációs köre. A nem opioid analgetikumok között az egyik legerősebb fájdalomcsillapító.
openaire   +1 more source

Pharmacology and relevant drug interactions of metamizole [PDF]

British Journal of Clinical Pharmacology
David J Brinkman
exaly   +2 more sources